European Journal of Vascular & Endovascular Surgery
Volume 36, Issue 4 , Pages 409-419 , October 2008

Clinical Endpoints in Peripheral Endovascular Revascularization Trials: a Case for Standardized Definitions

  • N. Diehm

      Affiliations

    • Swiss Cardiovascular Center, Division of Clinical and Interventional Angiology, Inselspital, University of Bern, Switzerland
    • Corresponding Author InformationCorresponding author. N. Diehm, Swiss Cardiovascular Center, Division of Clinical and Interventional Angiology, Inselspital, University of Bern, Freiburgstrasse, 3010 Bern, Switzerland. Tel.: +41 31 632 2111; fax: +41 31 632 4793.
    • ,
  • P.M. Pattynama

      Affiliations

    • Department of Radiology, Erasmus University Medical Center, Rotterdam, The Netherlands
    • ,
  • M.R. Jaff

      Affiliations

    • The Vascular Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    • ,
  • A. Cremonesi

      Affiliations

    • Gruppo Villa Maria Endovascular, Villa Maria Cecilia Hospital, Cotignola, Italy
    • ,
  • G.J. Becker

      Affiliations

    • Department of Radiology, Vascular & Interventional Section, and the Sarver Heart Center, University of Arizona College of Medicine
    • ,
  • L.N. Hopkins

      Affiliations

    • Department of Neurosurgery, School of Medicine and Biomedical Sciences, Buffalo, NY, USA
    • ,
  • F. Mahler

      Affiliations

    • Swiss Cardiovascular Center, Division of Clinical and Interventional Angiology, Inselspital, University of Bern, Switzerland
    • ,
  • A. Talen

      Affiliations

    • Genae associates nv, Antwerp, Belgium
    • ,
  • J.F. Cardella

      Affiliations

    • Department of Radiology, Baystate Health System/Tufts University School of Medicine, Springfield, Massachusetts
    • ,
  • S. Ramee

      Affiliations

    • Ochsner Heart and Vascular Institute, New Orleans, LA, USA
    • ,
  • M. van Sambeek

      Affiliations

    • Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands
    • ,
  • F. Vermassen

      Affiliations

    • Department of Vascular Surgery, University Hospital, Gent, Belgium
    • ,
  • G. Biamino

      Affiliations

    • Gruppo Villa Maria Endovascular, Villa Maria Cecilia Hospital, Cotignola, Italy

Received 16 April 2008 ,Accepted 14 June 2008.

References 

  1. Anderson PL, Gelijns A, Moskowitz A, Arons R, Gupta L, Weinberg A, et al. Understanding trends in inpatient surgical volume: vascular interventions, 1980–2000. J Vasc Surg. 2004;39:1200–1208
  2. Diehm N, Baumgartner I, Jaff M, Do DD, Minar E, Schmidli J, et al. A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries. Eur Heart J. 2007;28:798–805
  3. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517–538
  4. Sacks D, Marinelli DL, Martin LG, Spies JB. Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. J Vasc Interv Radiol. 2003;14:S395–S404
  5. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006;47:1239–1312
  6. Gardner AW, Skinner JS, Cantwell BW, Smith LK. Progressive vs single-stage treadmill tests for evaluation of claudication. Med Sci Sports Exerc. 1991;23:402–408
  7. EuroQol–a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy. 1990;16:199–208
  8. Regensteiner JG, Steiner JF, Panzer RJ, Hiatt WR. Evaluation of walking impairment by questionnaire in patients with peripheral arterial disease. J Vasc Med Biol. 1990;2:142–152
  9. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, et al. Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation. 2000;101:E16–E22
  10. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg. 2000;31:S1–S296
  11. The Seventh Report of the Joint National Committee on Prevention, Detection, and Treatment of High Blood Pressure: US Department of Health and Human Sciences; 2004.
  12. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227–239
  13. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183–1197
  14. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043–1049
  15. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  16. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(Suppl. 1):S1–S75
  17. Schillinger M, Diehm N, Baumgartner I, Minar E. TASC II section F on revascularization: commentary from an interventionist's point of view. J Endovasc Ther. 2007;14:734–742
  18. Ranke C, Hendrickx P, Roth U, Brassel F, Creutzig A, Alexander K. Color and conventional image-directed Doppler ultrasonography: accuracy and sources of error in quantitative blood flow measurements. J Clin Ultrasound. 1992;20:187–193
  19. International Standard ISO 14155, part 1 & 2-clinical investigations of medical devices for human subjects.
  20. ICH Topic E6, Guideline for Good Clinical Practice.
  21. Code of federal regulations, CRF 21, part 812-investigational device exemptions.
  22. Beregi JP, Martin-Teule C, Trogrlic S, Meunier JC, Crochet D. Quantitative angiography: update for peripheral vascular applications. J Radiol. 1999;80:835–841
  23. Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation. 2002;106:1505–1509
  24. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol. 2005;16:331–338
  25. Reiber J, Koning G, Tuinenburg J, Lansky A, Goedhart B. Quantitative coronary arteriography. In:  Oudkerk M editors. Coronary radiology. Berlin: Springer; 2004;p. 41–58
  26. Koelemay MJ, Legemate DA, van Gurp JA, de Vos H, Balm R, Jacobs MJ. Interobserver variation of colour duplex scanning of the popliteal,tibial and pedal arteries. Eur J Vasc Endovasc Surg. 2001;21:160–164
  27. Hingorani A, Ascher E, Markevich N, Kallakuri S, Hou A, Schutzer R, et al. Magnetic resonance angiography versus duplex arteriography in patients undergoing lower extremity revascularization: which is the best replacement for contrast arteriography?. J Vasc Surg. 2004;39:717–722
  28. Schlager O, Francesconi M, Haumer M, Dick P, Sabeti S, Amighi J, et al. Duplex sonography versus angiography for assessment of femoropopliteal arterial disease in a “real-world” setting. J Endovasc Ther. 2007;14:452–459
  29. Jaff M, Dake M, Pompa J, Ansel G, Yoder T. Standardized evaluation and reporting of stent fractures in clinical trials of noncoronary devices. Catheter Cardiovasc Interv. 2007;70:460–462
  30. Berkson J, Gage RP. Calculation of survival rates for cancer. Mayo Clin Proc. 1950;25:270–286
  31. Kaplan ML, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;457–481

PII: S1078-5884(08)00343-2

doi: 10.1016/j.ejvs.2008.06.020

European Journal of Vascular & Endovascular Surgery
Volume 36, Issue 4 , Pages 409-419 , October 2008

Article Tools